MPW, also known as Medical Properties Trust, has been a stalwart in the healthcare real estate investment trust (REIT) space for two decades. Founded in 2003, the company has grown significantly since its inception.
Its focus on providing capital to healthcare providers has been a key factor in its success. With a strong track record of acquisitions and strategic partnerships, MPW has established itself as a reliable player in the industry.
MPW's commitment to providing quality healthcare facilities has been evident in its investment strategy. The company has made strategic investments in various healthcare assets, including hospitals, surgery centers, and other medical facilities.
Through its 20-year history, MPW has demonstrated its ability to navigate the ever-changing healthcare landscape, making it an attractive option for investors seeking stability and growth.
Performance Metrics
Let's take a closer look at the performance metrics of MPW stock.
The previous close for MPW stock was $4.69.
The stock's day range was between $4.6 and $4.89, while its year range was between $2 and $6.
The market capitalization of MPW stock is a substantial $2,791,860,000.
It's listed on the NYSE, the New York Stock Exchange.
MPW stock has experienced significant revenue and earnings growth, with a revenue growth of -22.3% and an earnings growth of -48.6% year-over-year.
Here are some key performance metrics for MPW stock:
MPW stock's diluted EPS (TTM) is -$4.44, indicating a significant loss per share.
Fundamentals and Analysis
Medical Properties Trust Inc, with a market capitalization of $2,791,860 K, has a significant presence in the market. Its shares outstanding total 600,400 K.
The company's annual sales are substantial, standing at $871,800 K. However, its annual income is negative, at -$556,480 K. This indicates a significant loss for the company.
Medical Properties Trust Inc's EBIT stands at $66 M, while its EBITDA is significantly higher at $698 M. This suggests that the company's operating income is substantial, despite its negative annual income.
Here's a snapshot of the company's financial metrics:
The company's beta is 1.29, indicating a relatively high level of volatility. Medical Properties Trust Inc's price-to-sales ratio is 4.35, while its price-to-cash-flow ratio is 37.25.
Broaden your view: Meme Stock Price
Frequently Asked Questions
Is MPW a good stock to buy now?
MPW has a moderate buy signal with an average brokerage recommendation of 3.50, indicating a neutral stance among analysts. However, this rating alone may not be enough to determine if MPW is a good stock to buy now, and further research is recommended.
What is the MPW prediction for 2024?
MPW's predicted earnings for 2024 range from $462 million to $468 million, with an average forecast of $466.5 million. Analysts' forecasts suggest a relatively stable outlook for MPW's earnings in 2024.
What is the future of MPW?
According to Wall Street analysts, MPW stock is expected to increase by 19.95% in the next 12 months, with a predicted average price of $4.63. This forecast suggests a potential growth opportunity for investors, but it's essential to stay informed about the company's performance and market trends.
What is the dividend yield for MPW in 2024?
The dividend yield for Medical Properties Trust (MPW) in 2024 is 12.33% as of December 27, 2024. This yield indicates a potentially attractive investment opportunity for income-seeking investors.
Featured Images: pexels.com
